These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 23633235)
1. Cardiac and respiratory dysfunction in Duchenne muscular dystrophy and the role of second messengers. Mosqueira M; Zeiger U; Förderer M; Brinkmeier H; Fink RH Med Res Rev; 2013 Sep; 33(5):1174-213. PubMed ID: 23633235 [TBL] [Abstract][Full Text] [Related]
2. Pathophysiology and therapy of cardiac dysfunction in Duchenne muscular dystrophy. Judge DP; Kass DA; Thompson WR; Wagner KR Am J Cardiovasc Drugs; 2011 Oct; 11(5):287-94. PubMed ID: 21812510 [TBL] [Abstract][Full Text] [Related]
3. Decreased myocardial nNOS, increased iNOS and abnormal ECGs in mouse models of Duchenne muscular dystrophy. Bia BL; Cassidy PJ; Young ME; Rafael JA; Leighton B; Davies KE; Radda GK; Clarke K J Mol Cell Cardiol; 1999 Oct; 31(10):1857-62. PubMed ID: 10525423 [TBL] [Abstract][Full Text] [Related]
4. [Duchenne muscular dystrophy: rational basis, state of the art]. Palmieri B; Sblendorio V Recenti Prog Med; 2006 Sep; 97(9):441-7. PubMed ID: 17017293 [TBL] [Abstract][Full Text] [Related]
5. Nitric oxide-dependent attenuation of noradrenaline-induced vasoconstriction is impaired in the canine model of Duchenne muscular dystrophy. Kodippili K; Hakim CH; Yang HT; Pan X; Yang NN; Laughlin MH; Terjung RL; Duan D J Physiol; 2018 Nov; 596(21):5199-5216. PubMed ID: 30152022 [TBL] [Abstract][Full Text] [Related]
6. The anticancer drug tamoxifen counteracts the pathology in a mouse model of duchenne muscular dystrophy. Dorchies OM; Reutenauer-Patte J; Dahmane E; Ismail HM; Petermann O; Patthey- Vuadens O; Comyn SA; Gayi E; Piacenza T; Handa RJ; Décosterd LA; Ruegg UT Am J Pathol; 2013 Feb; 182(2):485-504. PubMed ID: 23332367 [TBL] [Abstract][Full Text] [Related]
7. Bradykinin restores left ventricular function, sarcomeric protein phosphorylation, and e/nNOS levels in dogs with Duchenne muscular dystrophy cardiomyopathy. Su JB; Cazorla O; Blot S; Blanchard-Gutton N; Ait Mou Y; Barthélémy I; Sambin L; Sampedrano CC; Gouni V; Unterfinger Y; Aguilar P; Thibaud JL; Bizé A; Pouchelon JL; Dabiré H; Ghaleh B; Berdeaux A; Chetboul V; Lacampagne A; Hittinger L Cardiovasc Res; 2012 Jul; 95(1):86-96. PubMed ID: 22562664 [TBL] [Abstract][Full Text] [Related]
8. Therapeutic strategies for Duchenne and Becker dystrophies. Voisin V; de la Porte S Int Rev Cytol; 2004; 240():1-30. PubMed ID: 15548414 [TBL] [Abstract][Full Text] [Related]
9. Dystrophin deficiency in canine X-linked muscular dystrophy in Japan (CXMDJ) alters myosin heavy chain expression profiles in the diaphragm more markedly than in the tibialis cranialis muscle. Yuasa K; Nakamura A; Hijikata T; Takeda S BMC Musculoskelet Disord; 2008 Jan; 9():1. PubMed ID: 18182116 [TBL] [Abstract][Full Text] [Related]
10. [Association between dystrophin and neuronal nitric oxide synthase in muscles of progressive muscular dystrophy]. Wang S; Shen D Zhonghua Yi Xue Za Zhi; 2002 Feb; 82(3):155-7. PubMed ID: 11953148 [TBL] [Abstract][Full Text] [Related]
11. Cardiomyopathy of Duchenne muscular dystrophy: pathogenesis and prospect of membrane sealants as a new therapeutic approach. Townsend D; Yasuda S; Metzger J Expert Rev Cardiovasc Ther; 2007 Jan; 5(1):99-109. PubMed ID: 17187461 [TBL] [Abstract][Full Text] [Related]
12. Electrocardiographic findings in mdx mice: a cardiac phenotype of Duchenne muscular dystrophy. Chu V; Otero JM; Lopez O; Sullivan MF; Morgan JP; Amende I; Hampton TG Muscle Nerve; 2002 Oct; 26(4):513-9. PubMed ID: 12362417 [TBL] [Abstract][Full Text] [Related]
13. Temporal gene expression profiling of dystrophin-deficient (mdx) mouse diaphragm identifies conserved and muscle group-specific mechanisms in the pathogenesis of muscular dystrophy. Porter JD; Merriam AP; Leahy P; Gong B; Feuerman J; Cheng G; Khanna S Hum Mol Genet; 2004 Feb; 13(3):257-69. PubMed ID: 14681298 [TBL] [Abstract][Full Text] [Related]
14. Nitric oxide and l-arginine cause an accumulation of utrophin at the sarcolemma: a possible compensation for dystrophin loss in Duchenne muscular dystrophy. Chaubourt E; Fossier P; Baux G; Leprince C; Israël M; De La Porte S Neurobiol Dis; 1999 Dec; 6(6):499-507. PubMed ID: 10600405 [TBL] [Abstract][Full Text] [Related]